{"entity":{"id":"nct05397093","kind":"trial","name":"ITIL-306 in Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of ITIL-306 run by Instil Bio, terminated.","summary":"ITIL-306 in Advanced Solid Tumors is a phase 1 interventional study registered as NCT05397093 by Instil Bio, with 1 participants enrolled, started 2022-08-24. Conditions recorded: Epithelial Ovarian Cancer, Non-small Cell Lung Cancer and Renal Cell Carcinoma. Interventions recorded: ITIL-306.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT05397093","url":"https://clinicaltrials.gov/study/NCT05397093"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["ovarian","nsclc","rcc"],"sections":[],"technologies":[],"targets":[],"drugs":["itil-306"],"companies":["instil-bio"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05397093","phase":"1","setting":"A Phase 1a/1b, Open-Label, Multicenter Study Evaluating the Safety and Feasibility of ITIL-306 in Subjects With Advanced Solid Tumors","sponsor":"Instil Bio","enrolled":1,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05397093/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"},{"id":"rcc","kind":"cancer","name":"Renal cell carcinoma","route":"/cancers/rcc/"}],"drug":[{"id":"itil-306","kind":"drug","name":"ITIL-306","route":"/drugs/itil-306/"}],"company":[{"id":"instil-bio","kind":"company","name":"Instil Bio","route":"/companies/instil-bio/"}]}}